DiscoverThe MedTech Experience#25 - Matt Wetzel: FDA Isn't the Finish
#25 - Matt Wetzel: FDA Isn't the Finish

#25 - Matt Wetzel: FDA Isn't the Finish

Update: 2025-07-19
Share

Description

www.lifeblood.com

Hosted by Giovanni Lauricella, in this episode we interview Matt Wetzel, Partner at Goodwin. Matt shares his industry expertise of legal and compliance issues as a legal representative of MedTech companies. Giovanni and Matt discuss changes and impacts from the current Presidential administration to the MedTech industry, regulatory reform, FDA layoffs, MedTech representation in Washington, DC, hotels and shamans, and more.

This episode is sponsored by Goodwin, a lifecycle legal firm with a specialized MedTech practice. To learn more about Goodwin's MedTech practice, visit www.goodwinlaw.com/en/people/g/gomez-martin or by emailing Martin Gomez directly at mgomez@goodwinlaw.com

Comments 
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#25 - Matt Wetzel: FDA Isn't the Finish

#25 - Matt Wetzel: FDA Isn't the Finish

Lifeblood.com